Clinical Trials Browser

Phase 2/3 × Methylphenidate × 90 days × Clear all

NCT03772834 2026-05-04

Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer

Phase 2/3 Active not recruiting

Prostatic Neoplasms